Literature DB >> 19048275

Is the balance between skeletal muscular metabolic capacity and oxygen supply capacity the same in endurance trained and untrained subjects?

Bjarne Rud1, Jostein Hallén.   

Abstract

We attempted to test whether the balance between muscular metabolic capacity and oxygen supply capacity in endurance-trained athletes (ET) differs from that in a control group of normal physically active subjects by using exercises with different muscle masses. We compared maximal exercise in nine ET subjects [Maximal oxygen uptake (VO(2)max) 64 ml kg(-1) min(-1) +/- SD 4] and eight controls (VO(2)max 46 +/- 4 ml kg(-1) min(-1)) during one-legged knee extensions (1-KE), two-legged knee extensions (2-KE) and bicycling. Maximal values for power output (P), VO(2)max, concentration of blood lactate ([La(-)]), ventilation (VE), heart rate (HR), and arterial oxygen saturation of haemoglobin (SpO(2)) were registered. P was 43 (2), 89 (3) and 298 (7) W (mean +/- SE); and VO(2)max: 1,387 (80), 2,234 (113) and 4,115 (150) ml min(-1)) for controls in 1-KE, 2-KE and bicycling, respectively. The ET subjects achieved 126, 121 and 126% of the P of controls (p < 0.05) and 127, 124, and 117% of their VO(2)max (p < 0.05). HR and [La(-)] were similar for both groups during all modes of exercise, while VE in ET was 147 and 114% of controls during 1-KE and bicycling, respectively. For mass-specific VO(2)max (VO(2)max divided by the calculated active muscle mass) during the different exercises, ET achieved 148, 141, and 150% of the controls' values, respectively (p < 0.05). During bicycling, both groups achieved 37% of their mass-specific VO(2) during 1-KE. Finally we conclude that ET subjects have the same utilization of the muscular metabolic capacity during whole body exercise as active control subjects.

Entities:  

Mesh:

Year:  2008        PMID: 19048275     DOI: 10.1007/s00421-008-0947-8

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  24 in total

1.  New ideas on limitations to VO2max.

Authors:  P D Wagner
Journal:  Exerc Sport Sci Rev       Date:  2000-01       Impact factor: 6.230

2.  The concept of symmorphosis: a testable hypothesis of structure-function relationship.

Authors:  E R Weibel; C R Taylor; H Hoppeler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 3.  Are the arms and legs in competition for cardiac output?

Authors:  Niels H Secher; Stefanos Volianitis
Journal:  Med Sci Sports Exerc       Date:  2006-10       Impact factor: 5.411

4.  Maximal perfusion of skeletal muscle in man.

Authors:  P Andersen; B Saltin
Journal:  J Physiol       Date:  1985-09       Impact factor: 5.182

5.  Central and regional circulatory effects of adding arm exercise to leg exercise.

Authors:  N H Secher; J P Clausen; K Klausen; I Noer; J Trap-Jensen
Journal:  Acta Physiol Scand       Date:  1977-07

Review 6.  Structural and functional limits for oxygen supply to muscle.

Authors:  H Hoppeler; E R Weibel
Journal:  Acta Physiol Scand       Date:  2000-04

7.  Peak skeletal muscle perfusion is maintained in patients with chronic heart failure when only a small muscle mass is exercised.

Authors:  G Magnusson; L Kaijser; C Sylvén; K E Karlberg; B Isberg; B Saltin
Journal:  Cardiovasc Res       Date:  1997-02       Impact factor: 10.787

8.  Dynamic knee extension as model for study of isolated exercising muscle in humans.

Authors:  P Andersen; R P Adams; G Sjøgaard; A Thorboe; B Saltin
Journal:  J Appl Physiol (1985)       Date:  1985-11

9.  Hemodynamics and O2 uptake during maximal knee extensor exercise in untrained and trained human quadriceps muscle: effects of hyperoxia.

Authors:  M Mourtzakis; J González-Alonso; T E Graham; B Saltin
Journal:  J Appl Physiol (1985)       Date:  2004-06-18

10.  Higher skeletal muscular metabolic reserve capacity in COPD patients than healthy subjects.

Authors:  B Rud; C C Christensen; M Ryg; A Edvardsen; S Skumlien; J Hallén
Journal:  Scand J Med Sci Sports       Date:  2009-08-05       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.